We invest in deep-tech founders who use frontier technology to solve the world's greatest challenges.
Discover the Fund ↓We curate scientist-founders passionate about entrepreneurship and frontier technology, building companies that deliver real value and lasting impact aligned with the UN Sustainable Development Goals.
Patient capital with no exit pressure. We build long-term relationships and support companies through every stage of their journey unconstrained by fund timelines.
Our managers are also investors. No performance fees means no misaligned incentives. We succeed only when our portfolio companies succeed.
A unique mechanism that redistributes excess gains to reinvest in the ecosystem, strengthening the chain of value and enabling more circular outcomes.
Six principles guide every decision we make, from how we source founders to how we structure governance.
A singular opportunity to build a healthy and fair model at the most critical and least competitive moment.
Responsible development tied to preserving critical performance indicators. Never sacrificing quality for speed.
Returns based on consistent result flows, not perverse growth cycles and irrational multiple projections.
We actively shape the management culture of our portfolio, focusing on the point of balance and sustainable profitability.
A fairer distribution of results to all stakeholders: founders, investors, employees and the broader community.
More decentralized political and economic power. Decisions made through consent, not command.
A proprietary methodology inspired by Geoffrey Moore's Crossing the Chasm: a new way to originate and develop resources, people and opportunities to achieve rapid progress even in complex deep-tech contexts.
Find a Charismatic, Result-Driven Founder
Sell Something
Sell Different Things in Different Ways
Sell One Thing in Different Ways
One Customer Profile, One Channel and One Product
Prepare the Backstage to Grow
Keep Doing the Great Job, Team
Long-lasting investment cycles and better financing conditions for ESG-aligned initiatives.
International certification movements and conscious markets increasingly valuing regenerative products and services.
Deep access to scientific development grants and the largest pool of scientist-founders in Latin America.
Aligned with the UN Sustainable Development Goals. Priority sectors for the next few years, based on proven innovation momentum across Latin America's market:
We prioritize sectors where our accumulated expertise and network create the greatest edge in identifying and accelerating transformative scientist-founders.
Industrial IoT, robotics and cobots transforming traditional industries at scale
Computer vision, natural language processing and machine learning applied to real-world problems
Bio-molecules, bio-systems, bio-computation, bioprinting and advanced biomaterials
Five companies at the frontier of science and technology, each founded by scientist-founders solving real-world problems.
Data Science applied to male sperm analysis to support cancer diagnosis with greater precision and accessibility.
Evidence-based pedagogical strategies and educational solutions supporting public schools to accelerate learning recovery and promote educational equity.
Computer vision for intelligent management in the animal protein supply chain. Partnerships with IPT, USP and UFABC. Supported by Finep, Fapesp and Fapemig.
IoT for digital revolution in physiotherapy and biomechanics. Serving clients across 8 countries with contracts in major industrial groups.
Biofabrication of human extracellular matrix for regenerative medicine and cosmetics. 12 market verticals explored with 3 proofs of concept underway.
Computer vision and AI to boost productivity in sugarcane and soybean fields. International patents developed with Embrapa. Google Israel AI Award winner.
Our structure is designed to align incentives, protect investors and enable patient capital deployment without artificial constraints.
Up to 100% participation in early-stage rounds valued below $400K. Up to 50% in larger rounds to ensure third-party co-investment validation and prevent over-concentration. Maximum of 10 portfolio companies at any time to preserve full methodological integrity.
Advisory board with quarterly meetings. Consent of both managers required on all material decisions. Sociocratic principles applied to all governance processes. Full transparency with quarterly reporting and unrestricted investor access.
Minimum LP investment commitment per entry. Returns to investors follow a defined methodology tied to portfolio performance, ensuring responsible capital deployment and sustainable distributions aligned with long-term value creation.
Interested in investing or partnering with Cons Ciência? We would love to hear from you.